Oxford Covid-19 vaccine boost as it shows 'strong immune response' in elderly
Published
The vaccine is currently in phase three clinical trials and the fact it is able to produce a strong response in all ages is extremely promising.
Full ArticlePublished
The vaccine is currently in phase three clinical trials and the fact it is able to produce a strong response in all ages is extremely promising.
Full ArticleEarly data suggests a good immune response in both younger and older adults
(Reuters) - Early results from tests for a coronavirus vaccine being developed by the University of Oxford, in collaboration with..
LONDON (AP) — The European Medicines Agency has started a “rolling review” process for the COVID-19 vaccine being developed..